Payer Contact in a “Contactless” World: Achieving Early Engagement
The COVID-19 pandemic has prompted life sciences organizations to quickly pivot their payer strategic approach and tactical implementation. Engaging payers [...]
Payer Contact in a “Contactless” World: Achieving Early Engagement
In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform.
Digital Transformation: Shaping the Future of Market Access
In the final part of her series on digital transformation in market access, Dr. Patti Peeples, CEO of HealthEconomics.com, and [...]
Clayton-Welch: Quality, Speed, Compliance Key in Dynamic Market Access Landscape
In the second of her five-part series on digital transformation in market access, HealthEconomics.Com© LLC CEO Patti Peeples sits down [...]
Transforming legacy approaches to understanding drug costs: An Interview with HealthPlanView’s Nicole Espinoza
Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Nicole Espinoza, Vice President of Knowledge Management at Pharmspective, a Healthcare [...]
Real-world evidence and value-based contracting – swipe left or swipe right?
As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, [...]
Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?
While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers (PBMs) have [...]
CVS Caremark’s foray into cost-effectiveness analysis raises questions about the future of prescription medicines in America
Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, [...]
Job Market for HEOR & Market Access: Success Strategies
The job market for HEOR, Market Access, Medical Affairs, and Real World Evidence is as hot as an Arizona airport [...]
Industry Groups Challenge Readiness of ICER’s Value Framework
Healthcare is all about making decisions. Who to treat? When to treat? How to treat? How long to treat? How [...]
Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.
Swarali Tadwalker, MPH Hardly a day goes by without a new article being published in the mainstream press [...]
Health Informatics, A Fast-Growing Field and a Crucial Skill-Set: An Interview with Dr. Patrick Casimir
What is Health Informatics? What discipline combines information technology, programming, analytical skills, communication abilities, and a deep desire to improve [...]
Salary Survey 2015 for HEOR & Market Access Just Released!
HealthEconomics.Com, in collaboration with MedLitera LLC, conducted the industry’s largest global salary survey for the health economics & outcomes research [...]
Is Email Marketing Dead? Nope, Not If You Follow These Tips!
Bad news: Email marketing isn't as effective as it used to be. Good news: It's still effective. And, it still provides great ROI [...]
Playing in the Real World Evidence Sandbox: Sharing, Teamwork, and Transparency
Is just playing in the same sandbox together an example of Real World Evidence (RWE) collaboration? Not really. So how [...]
Achieving Market Access in India – Are You Hitting the Mark? An Interview with Marksman Healthcare Solutions CEO Dr. Amit Dang
It’s well-accepted that the Indian pharmaceuticals market cannot be ignored. India will be one of the top 10 sales markets [...]
